NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

The National Institutes of Health is seeking applications for the NIAMS Clinical Trial Implementation Cooperative Agreement. This opportunity aims to support clinical trials that address the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The award will be made as a cooperative agreement, and applicants are expected to propose a clinical trial that meets the requirements outlined in the funding opportunity announcement. Key aspects of this opportunity include: • The clinical trial must be relevant to the NIAMS mission • The award will be made as a cooperative agreement • Applicants must propose a clinical trial that meets the requirements outlined in the funding opportunity announcement • The opportunity is open to various types of applicants, including public and state-controlled institutions of higher education, private institutions of higher education, and non-profit organizations • The application submission deadline is March 4, 2027